1
|
Hamilton E, Oliveira M, Turner N, García-Corbacho J, Hernando C, Ciruelos EM, Kabos P, Borrego MR, Armstrong A, Patel MR, Vaklavas C, Twelves C, Boni V, Incorvati J, Brier T, Gibbons L, Klinowska T, Lindemann JPO, Morrow CJ, Sykes A, Baird R. A Phase 1 dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results. Ann Oncol 2024:S0923-7534(24)00138-8. [PMID: 38729567 DOI: 10.1016/j.annonc.2024.04.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2024] [Revised: 04/26/2024] [Accepted: 04/29/2024] [Indexed: 05/12/2024] Open
Abstract
BACKGROUND SERENA-1 (NCT03616587) is a Phase 1, multi-part, open-label study of camizestrant in pre- and post-menopausal women with ER+, HER2- advanced breast cancer. Parts A and B aim to determine the safety and tolerability of camizestrant monotherapy and define doses for clinical evaluation. Patients and Methods Women aged 18 years or older with metastatic or recurrent ER+, HER2- breast cancer, refractory (or intolerant) to therapy were assigned 25 mg up to 450 mg once daily (QD; escalation) or 75, 150, or 300 mg QD (expansion). Safety and tolerability, anti-tumor efficacy, pharmacokinetics, and impact on ESR1m circulating tumor (ct)DNA levels were assessed. RESULTS By 9 March 2021, 108 patients received camizestrant monotherapy at 25-450 mg doses. Of these, 93 (86.1%) experienced treatment-related adverse events (TRAEs), 82.4% of which were grade 1 or 2. The most common TRAEs were visual effects (56%), (sinus) bradycardia (44%), fatigue (26%), and nausea (15%). There were no TRAEs grade 3 or higher, or treatment-related serious adverse events (TRSAEs) at doses ≤150 mg. Median tmax was achieved ∼2-4 hours post-dose at all doses investigated, with an estimated half-life of 20-23 hours. Efficacy was observed at all doses investigated, including in patients with prior CDK4/6 inhibitor and/or fulvestrant treatment, with and without baseline ESR1 mutations, and with visceral disease, including liver metastases. CONCLUSIONS Camizestrant is a next-generation oral SERD and pure ER antagonist with a tolerable safety profile. The pharmacokinetics profile supports once-daily dosing, with evidence of pharmacodynamic and clinical efficacy in heavily pre-treated patients, regardless of ESR1m. This study established 75, 150 and 300 mg QD doses for Phase 2 testing (SERENA-2, NCT04214288 and SERENA-3, NCT04588298).
Collapse
Affiliation(s)
- E Hamilton
- Sarah Cannon Research Institute, Nashville, TN, USA
| | - M Oliveira
- Medical Oncology Department, Vall d'Hebron University Hospital and Breast Cancer Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain
| | - N Turner
- Breast Cancer Now, Toby Robins Research Centre, Institute of Cancer Research, London, UK
| | | | - C Hernando
- Department of Medical Oncology, Hospital Clinico Universitario de Valencia, Biomedical Research Institute (INCLIVA), Valencia, Spain
| | - E M Ciruelos
- Medical Oncology Department, 12 de Octubre University Hospital, Madrid, Spain
| | - P Kabos
- Division of Medical Oncology, University of Colorado, CO, USA
| | - M R Borrego
- Department of Medical Oncology, H U Virgen del Rocio, Seville, Spain
| | - A Armstrong
- The Christie NHS Foundation Trust and the University of Manchester, Manchester, UK
| | - M R Patel
- Florida Cancer Specialists/Sarah Cannon Research Institute/Sarasota Memorial Hospital, Sarasota, FL, USA
| | - C Vaklavas
- Huntsman Cancer Institute, University of Utah, UT, USA
| | - C Twelves
- Leeds Teaching Hospitals NHS Trust and University of Leeds, Leeds, UK
| | - V Boni
- START Madrid, CIOCC, Madrid, Spain
| | - J Incorvati
- Fox Chase Cancer Center, East Norriton-Hospital Outpatient Center, Philadelphia, PA, USA
| | - T Brier
- Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK
| | - L Gibbons
- Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK
| | - T Klinowska
- Late Development, Oncology R&D, AstraZeneca, Cambridge, UK
| | - J P O Lindemann
- Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK
| | - C J Morrow
- Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK
| | - A Sykes
- Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK
| | - R Baird
- Cancer Research UK, Cambridge Centre, Cambridge, UK.
| |
Collapse
|
2
|
Vilar E, Collado-Boira E, Guerrero C, Folch-Ayora A, Salas-Medina P, Hernando C, Baliño P, Muriach M. Is There a Role of Beetroot Consumption on the Recovery of Oxidative Status and Muscle Damage in Ultra-Endurance Runners? Nutrients 2024; 16:583. [PMID: 38474711 DOI: 10.3390/nu16050583] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2024] [Revised: 02/10/2024] [Accepted: 02/16/2024] [Indexed: 03/14/2024] Open
Abstract
(1) Background: Ultra-endurance exercise involves a high physical impact, resulting in muscle damage, inflammatory response and production of free radicals that alter the body's oxidative state. Supplementation with antioxidants, such as beetroot, may improve recovery in ultra-endurance runners. The aim of this study was to determine whether there is a correlation between beetroot intake and recovery of serum oxidative status, inflammatory response and muscle damage parameters after an ultra-endurance race. (2) Methods: An observational and longitudinal study was conducted by means of surveys and blood samples collected from 32 runners during the IX Penyagolosa Trails CSP®® race and the two following days. The variables C-reactive protein (CRP), lactate dehydrogenase (LDH), creatine kinase (CK), the activity of the antioxidant enzymes glutathione peroxidase (GPx) and glutathione reductase (GR) as well as the oxidative damage markers malondialdehyde (MDA), carbonyl groups (CG) and loss of muscle strength using the squat jump (SJ) test were analyzed to discriminate whether beetroot consumption can modulate the recovery of ultra-trail runners. (3) Results: Significant differences were observed between runners who ingested beetroot and those who did not, in terms of oxidative status, specifically in serum GPx activity at 24 and 48 h, muscle damage variables CK and LDH and regarding the SJ test results at the finish line. Therefore, the intake of supplements containing beetroot positively influences the recovery of serum oxidative status and muscle damage after ultra-endurance running.
Collapse
Affiliation(s)
- Eva Vilar
- Hospital de La Plana, Vila-Real, 12540 Castellon, Spain
| | - Eladio Collado-Boira
- Unidad Predepartamental de Enfermeria, Jaume I University, 12071 Castellon, Spain
| | - Carlos Guerrero
- Unitat Predepartamental de Medicina, Jaume I University, 12071 Castellón, Spain
| | - Ana Folch-Ayora
- Unidad Predepartamental de Enfermeria, Jaume I University, 12071 Castellon, Spain
| | - Pablo Salas-Medina
- Unidad Predepartamental de Enfermeria, Jaume I University, 12071 Castellon, Spain
| | - Carlos Hernando
- Department of Education and Specific Didactics, Sport Service, Jaume I University, 12071 Castellon, Spain
| | - Pablo Baliño
- Unitat Predepartamental de Medicina, Jaume I University, 12071 Castellón, Spain
| | - María Muriach
- Unitat Predepartamental de Medicina, Jaume I University, 12071 Castellón, Spain
| |
Collapse
|
3
|
Hernando C, Hernando C, Panizo N, Collado-Boira E, Folch-Ayora A, Martínez-Navarro I, Hernando B. Renal Function Recovery Strategies Following Marathon in Amateur Runners. Front Physiol 2022; 13:812237. [PMID: 35295572 PMCID: PMC8918951 DOI: 10.3389/fphys.2022.812237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Accepted: 01/24/2022] [Indexed: 11/13/2022] Open
Abstract
Long distance races have a physiological impact on runners. Up to now, studies analyzing these physiological repercussions have been mainly focused on muscle and cardiac damage, as well as on its recovery. Therefore, a limited number of studies have been done to explore acute kidney failure and recovery after performing extreme exercises. Here, we monitored renal function in 76 marathon finishers (14 females) from the day before participating in a marathon until 192 h after crossing the finish line (FL). Renal function was evaluated by measuring serum creatinine (sCr) and the glomerular filtration rate (GFR). We randomly grouped our cohort into three intervention groups to compare three different strategies for marathon recovery: total rest (REST), continuous running at their ventilatory threshold 1 (VT1) intensity (RUN), and elliptical workout at their VT1 intensity (ELLIPTICAL). Interventions in the RUN and ELLIPTICAL groups were performed at 48, 96, and 144 h after marathon running. Seven blood samples (at the day before the marathon, at the FL, and at 24, 48, 96, 144, and 192 h post-marathon) and three urine samples (at the day before the marathon, at the finish line, and at 48 h post-marathon) were collected per participant. Both heart rate monitors and triaxial accelerometers were used to control the intensity effort during both the marathon race and the recovery period. Contrary to our expectations, the use of elliptical machines for marathon recovery delays renal function recovery. Specifically, the ELLIPTICAL group showed a significantly lower ∆GFR compared to both the RUN group (p = 4.5 × 10−4) and the REST group (p = 0.003). Hence, we encourage runners to carry out an active recovery based on light-intensity continuous running from 48 h after finishing the marathon. In addition, full resting seems to be a better strategy than performing elliptical workouts.
Collapse
Affiliation(s)
- Carlos Hernando
- Sport Service, Jaume I University, Castellon, Spain
- Department of Education and Specific Didactics, Jaume I University, Castellon, Spain
- *Correspondence: Carlos Hernando,
| | - Carla Hernando
- Department of Mathematics, Carlos III University of Madrid, Madrid, Spain
| | - Nayara Panizo
- Nephrology Service, University Clinical Hospital of Valencia, Valencia, Spain
| | | | - Ana Folch-Ayora
- Faculty of Health Sciences, Jaume I University, Castellon, Spain
| | - Ignacio Martínez-Navarro
- Department of Physical Education and Sport, University of Valencia, Valencia, Spain
- Sports Health Unit, Vithas-Nisa 9 de Octubre Hospital, Valencia, Spain
| | | |
Collapse
|
4
|
Martinez-Navarro I, Collado E, Hernando B, Hernando C. Pulmonary and Inspiratory Muscle Function Response to a Mountain Ultramarathon. J Sports Sci Med 2021; 20:706-713. [PMID: 35321133 PMCID: PMC8488829 DOI: 10.52082/jssm.2021.706] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2021] [Accepted: 08/18/2021] [Indexed: 06/14/2023]
Abstract
The study aimed to provide within-race data on the time course of pulmonary function during a mountain ultramarathon (MUM). Additionally, we wanted to assess possible sex differences regarding pre- to post-race change in pulmonary and inspiratory muscle function. Lastly, we were interested in evaluating whether changes in respiratory function were associated with relative running speed and due to general or specific fatigue. 47 athletes (29 males and 18 females; 41 ± 5 years) were submitted to a cardiopulmonary exercise test (CPET) before a 107-km MUM. Spirometric variables: forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), FEV1/FVC and peak expiratory flow (PEF); maximal inspiratory pressure (MIP); squat jump (SJ) and handgrip strength (HG) were assessed before and after the race. Additionally PEF was measured at three aid stations (33rd, 66th and 84th km) during the race. PEF declined from the 33rd to the 66th km (p = 0.004; d = 0.72) and from the 84th km to the finish line (p = 0.003; d = 0.90), while relative running speed dropped from the first (0-33 km) to the second (33-66 km) race section (p < 0.001; d = 1.81) and from the third (66-84 km) to the last race section (p < 0.001; d = 1.61). Post-race, a moderate reduction was noted in FVC (-13%; p < 0.001; d = 0.52), FEV1 (-19.5%; p < 0.001; d = 0.65), FEV1/FVC (-8.4%; p = 0.030; d = 0.59), PEF (-20.3%; p < 0.001; d = 0.58), MIP (-25.3%; p < 0.001; d = 0.79) and SJ (-31.6%; p < 0.001; d = 1.42). Conversely, HG did not change from pre- to post-race (-1.4%; p = 0.56; d = 0.05). PEF declined during the race in parallel with running speed drop. No sex differences were noted regarding post-race respiratory function, except that FEV1/FVC decay was significantly greater among women. The magnitude of pre- to post-race respiratory function decline was uncorrelated with relative running speed.
Collapse
Affiliation(s)
- Ignacio Martinez-Navarro
- Physical Education and Sports Department, University of Valencia, Valencia, Spain
- Sports Health Unit, Vithas 9 de Octubre Hospital, Valencia, Spain
| | - Eladio Collado
- Faculty of Health Sciences, Jaume I University, Castellon, Spain
| | | | - Carlos Hernando
- Sport Service, Jaume I University, Castellon, Spain
- Department of Education and Specific Didactics, Jaume I University, Castellon, Spain
| |
Collapse
|
5
|
Madrigal J, Martín A, Chambel R, Guijarro M, Hernando C, Callejas M, Espinosa J, Climent J. Do cone age and heating mode determine the opening of serotinous cones during wildfires? A new bench scale approach applied to Pinus halepensis Mill. Sci Total Environ 2021; 763:144222. [PMID: 33383513 DOI: 10.1016/j.scitotenv.2020.144222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/18/2020] [Revised: 11/25/2020] [Accepted: 11/25/2020] [Indexed: 06/12/2023]
Abstract
Serotiny is a well-known fire adaptive trait in some species, as the Mediterranean conifer Pinus halepensis. However, information about cone opening mechanisms during wildfires and consequences on post fire dispersal is scarce. In addition, standardized methods allowing a realistic simulation of heating modes at bench-scale are not available. In this study, we address for the first time the interacting effects of radiation, convection and direct flame on the opening and seed release of serotinous cones, following a novel repeatable methodology. Using a Mass Loss Calorimeter (MLC) device and a wide range of heat exposures (between 5 and 75 kW m-2) with or without ignition, we intended to simulate realistic cone heating during surface and crown fires in laboratory conditions. Additionally, we included the effect of contrasting serotinous cone ages interacting with heating mode and considering the random individual variation. The proposed methodology has shown a high potential to simulate the complex process of crown fires in relation to cone opening under controlled conditions, detecting a threshold of heat exposure (25-30 kW m-2) for cone opening. We confirmed that heating mode had a highly significant effect in cone opening, interacting with cone age, while cone age effect on its own was marginal. Particularly, ignition significantly increased the efficacy of cone opening and seed release. Moreover, young and old cones behave differently in seed release, both in surface and crown fire simulations. Implementing and adjusting this methodology in other species will allow more realistic and reliable quantitative comparisons than previously attained.
Collapse
Affiliation(s)
- J Madrigal
- INIA, Forest Research Centre, Department of Forest Dynamics and Management, Forest Fire Laboratory, Ctra. Coruña Km 7,5, 28040 Madrid, Spain; iuFOR, University Institute for Sustainable Forest Management, UVA-INIA, Spain; ETSI Montes, Forestal y del Medio Natural, University Politechnic of Madrid (UPM), Ramiro de Maeztu s/n, 28040 Madrid, Spain.
| | - A Martín
- ETSI Montes, Forestal y del Medio Natural, University Politechnic of Madrid (UPM), Ramiro de Maeztu s/n, 28040 Madrid, Spain
| | - R Chambel
- INIA, Forest Research Centre, Department of Forest Ecology and Genetics, Genetics Laboratory, Ctra. Coruña Km 7,5, 28040 Madrid, Spain
| | - M Guijarro
- INIA, Forest Research Centre, Department of Forest Dynamics and Management, Forest Fire Laboratory, Ctra. Coruña Km 7,5, 28040 Madrid, Spain; iuFOR, University Institute for Sustainable Forest Management, UVA-INIA, Spain
| | - C Hernando
- INIA, Forest Research Centre, Department of Forest Dynamics and Management, Forest Fire Laboratory, Ctra. Coruña Km 7,5, 28040 Madrid, Spain; iuFOR, University Institute for Sustainable Forest Management, UVA-INIA, Spain
| | - M Callejas
- INIA, Forest Research Centre, Department of Forest Ecology and Genetics, Genetics Laboratory, Ctra. Coruña Km 7,5, 28040 Madrid, Spain
| | - J Espinosa
- INIA, Forest Research Centre, Department of Forest Dynamics and Management, Forest Fire Laboratory, Ctra. Coruña Km 7,5, 28040 Madrid, Spain; iuFOR, University Institute for Sustainable Forest Management, UVA-INIA, Spain
| | - J Climent
- iuFOR, University Institute for Sustainable Forest Management, UVA-INIA, Spain; INIA, Forest Research Centre, Department of Forest Ecology and Genetics, Genetics Laboratory, Ctra. Coruña Km 7,5, 28040 Madrid, Spain
| |
Collapse
|
6
|
Martínez-Navarro I, Collado E, Hernando C, Hernando B, Hernando C. Inflammation, muscle damage and postrace physical activity following a mountain ultramarathon. J Sports Med Phys Fitness 2021; 61:1668-1674. [PMID: 33555667 DOI: 10.23736/s0022-4707.21.11977-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND The study aimed at exploring whether muscle membrane disruption, as a surrogate for muscle damage, and inflammation recovery following a mountain ultramarathon (MUM) was related with race performance and postrace physical activity. METHODS Blood samples were obtained from thirty-four athletes (29 men and 5 women) before a 118-km MUM, immediately after and three- and seven-days postrace. Creatine kinase (CK), lactate dehydrogenase (LDH) and C-reactive protein (CRP) were compared between faster (FR) and slower (SR) runners. Physical activity performed during the week following the MUM was objectively analyzed using accelerometers and compared between FR and SR. RESULTS CK was significantly higher in FR at 3 days postrace (P<0.012, d=1.17) and LDH was significantly higher in FR at 3- and 7-days postrace (P=0.005, d=1.01; P<0.015, d=1.05 respectively), as compared to SR. No significant differences were identified in postrace physical activity levels between FR and SR. Significant relationships were found between race time and CK and LDH concentrations at 3 days postrace (r<inf>s</inf>=-0.41, P=0.017; r<inf>s</inf>=-0.52, P=0.002 respectively) and 7 days postrace (r<inf>s</inf>=-0.36, P=0.039; r<inf>s</inf>=-0.46. P=0.007 respectively). However, postrace physical activity was not associated with muscle damage and inflammation recovery, except for light intensity and CRP at 3 days postrace (r<inf>s</inf>=-0.40, P=0.025). CONCLUSIONS Race time appeared to have a higher influence on muscle damage recovery than the intensity of physical activities performed in the week after running a MUM. Inflammatory activity takes longer to normalize than muscle damage following a MUM, it is not related with race time and lightly related with postrace physical activity.
Collapse
Affiliation(s)
- Ignacio Martínez-Navarro
- Department of Physical Education and Sports, University of Valencia, Valencia, Spain - .,Unit of Sports Health -
| | | | - Carla Hernando
- Faculty of Health Sciences, Jaume I University, Castellon, Spain
| | | | - Carlos Hernando
- Department of Medicine, Jaume I University, Castellon, Spain.,Sport Service, Jaume I University, Castellon, Spain
| |
Collapse
|
7
|
Martínez-Navarro I, Montoya-Vieco A, Hernando C, Hernando B, Panizo N, Collado E. The week after running a marathon: Effects of running vs elliptical training vs resting on neuromuscular performance and muscle damage recovery. Eur J Sport Sci 2021; 21:1668-1674. [PMID: 33251988 DOI: 10.1080/17461391.2020.1857441] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Our aim was to compare the effects of two exercise modalities vs resting on the time course of neuromuscular performance and muscle damage recovery during the week after running a marathon. Sixty-four finishers from a road marathon completed the study (54 men and 10 women; 39 ± 4 years; 3 h 35 min ± 21 min). The day before the race, within 15 min after finishing the marathon and at 24, 48, 96, 144 and 192 h postrace, lactate dehydrogenase and creatine kinase were analysed. Participants also performed a squat jump (SJ) test before and after the marathon and at 48, 96 and 144 h postrace. On their arrival to the finish line, participants were randomized into one of the three intervention groups: running (RUN), elliptical training (ELIP) and resting recovery (REST). RUN and ELIP groups exercised continuously for 40 min at a moderate intensity (95-105% of the HR corresponding to the first ventilatory threshold) at 48, 96 and 144 h after the marathon. Neither 'Intervention' factor nor 'Intervention x Time' interaction effects were revealed for muscle damage blood markers (p > 0.05). On the other hand, RUN group evidenced an enhancement in SJ performance 96 h post-marathon as compared with REST group (108.29 ± 10.64 vs 100.58 ± 9.16%, p = 0.020, d = 0.80). Consequently, return to running at 48 h post-marathon does not seem to have a negative impact on muscle damage recovery up to eight days post-race and it could be recommended in order to speed up neuromuscular recovery.
Collapse
Affiliation(s)
- I Martínez-Navarro
- Physical Education and Sports Department, University of Valencia, Valencia, Spain.,Sports Health Unit, Vithas 9 de Octubre Hospital, Valencia, Spain
| | - A Montoya-Vieco
- Physical Education and Sports Department, University of Valencia, Valencia, Spain.,Sports Health Unit, Vithas 9 de Octubre Hospital, Valencia, Spain
| | - C Hernando
- Sport Service, Jaume I University, Castellon, Spain.,Department of Education and Specific Didactics, Jaume I University, Castellon, Spain
| | - B Hernando
- Department of Medicine, Jaume I University, Castellon, Spain
| | - N Panizo
- Department of Medicine, Jaume I University, Castellon, Spain.,Universitary Clinical Hospital of Valencia, Valencia, Spain
| | - E Collado
- Faculty of Health Sciences, Jaume I University, Castellon, Spain
| |
Collapse
|
8
|
Martinez-Navarro I, Montoya-Vieco A, Collado E, Hernando B, Hernando C. Inspiratory and Lower-Limb Strength Importance in Mountain Ultramarathon Running. Sex Differences and Relationship with Performance. Sports (Basel) 2020; 8:sports8100134. [PMID: 33066606 PMCID: PMC7602444 DOI: 10.3390/sports8100134] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2020] [Revised: 10/09/2020] [Accepted: 10/13/2020] [Indexed: 12/20/2022] Open
Abstract
The study was aimed at comparing lower-limb strength and respiratory parameters between male and female athletes and their interaction with performance in a 107 km mountain ultramarathon. Forty seven runners (29 males and 18 females; mean ± SD age: 41 ± 5 years) were enrolled. Lower-limb strength assessment comprised a squat jump test, an ankle rebound test, and an isometric strength test. Respiratory assessment included pulmonary function testing and the measurement of maximal inspiratory pressure. Male athletes performed largely better in the squat jump (26 ± 4 vs. 21 ± 3 cm; p < 0.001; d = 1.48), while no sex differences were found in the other two lower-limb tests. Concerning the respiratory parameters, male athletes showed largely greater values in pulmonary expiratory variables: forced vital capacity (5.19 ± 0.68 vs. 3.65 ± 0.52 L; p < 0.001; d = 2.53), forced expiratory volume in 1 s (4.24 ± 0.54 vs. 2.97 ± 0.39 L; p < 0.001; d = 2.69), peak expiratory flow (9.9 ± 1.56 vs. 5.89 ± 1.39 L/min; p < 0.001; d = 2.77) and maximum voluntary ventilation in 12 s (171 ± 39 vs. 108 ± 23 L/min; p < 0.001; d = 1.93); while no sex differences were identified in maximal inspiratory pressure. Race time was associated with ankle rebound test performance (r = −0.390; p = 0.027), isometric strength test performance (r = −0.349; p = 0.049) and maximal inspiratory pressure (r = −0.544; p < 0.001). Consequently, it seems that athletes competing in mountain ultramarathons may benefit from improving lower-limb isometric strength, ankle reactive strength and inspiratory muscle strength. Nevertheless, further interventional studies are required to confirm these exploratory results. In addition, the fact that the magnitude of the sex difference for isometric strength was minor, as compared with the other strength tests, could represent one of the factors explaining why the performance gap between males and females is reduced in ultramarathons.
Collapse
Affiliation(s)
- Ignacio Martinez-Navarro
- Physical Education and Sports Department, University of Valencia, 46010 Valencia, Spain;
- Sports Health Unit, Vithas 9 de Octubre Hospital, 46015 Valencia, Spain
- Correspondence:
| | - Antonio Montoya-Vieco
- Physical Education and Sports Department, University of Valencia, 46010 Valencia, Spain;
- Sports Health Unit, Vithas 9 de Octubre Hospital, 46015 Valencia, Spain
| | - Eladio Collado
- Faculty of Health Sciences, Jaume I University, 12071 Castellon, Spain;
| | - Bárbara Hernando
- Department of Medicine, Jaume I University, 12071 Castellon, Spain;
| | - Carlos Hernando
- Sport Service, Jaume I University, 12071 Castellon, Spain;
- Department of Education and Specific Didactics, Jaume I University, 12071 Castellon, Spain
| |
Collapse
|
9
|
Martinez-Navarro I, Montoya-Vieco A, Collado E, Hernando B, Hernando C. Ultra Trail Performance is Differently Predicted by Endurance Variables in Men and Women. Int J Sports Med 2020; 43:600-607. [PMID: 33017851 DOI: 10.1055/a-1255-3083] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
The study aimed to assess the relationship between peak oxygen uptake, ventilatory thresholds and maximal fat oxidation with ultra trail male and female performance. 47 athletes (29 men and 18 women) completed a cardiopulmonary exercise test between 2 to 4 weeks before a 107-km ultra trail. Body composition was also analyzed using a bioelectrical impedance weight scale. Exploratory correlation analyses showed that peak oxygen uptake (men: r=-0.63, p=0.004; women: r=-0.85, p < 0.001), peak speed (men: r=-0.74, p < 0.001; women: r=-0.69, p=0.009), speed at first (men: r=-0.49, p=0.035; women: r=-0.76, p=0.003) and second (men: r=-0.73, p < 0.001; women: r=-0.76, p=0.003) ventilatory threshold, and maximal fat oxidation (men: r=-0.53, p=0.019; women: r=-0.59, p=0.033) were linked to race time in male and female athletes. Percentage of fat mass (men: r=0.58, p=0.010; women: r=0.62, p= 0.024) and lean body mass (men: r=-0.61, p=0.006; women: r=-0.61, p=0.026) were also associated with performance in both sexes. Subsequent multiple regression analyses revealed that peak speed and maximal fat oxidation together were able to predict 66% of male performance; while peak oxygen uptake was the only statistically significant variable explaining 69% of the variation in women's race time. These results, although exploratory in nature, suggest that ultra trail performance is differently predicted by endurance variables in men and women.
Collapse
Affiliation(s)
- Ignacio Martinez-Navarro
- Department of Physical Education and Sports, Universitat de Valencia, Valencia.,Sports Health Unit, Vithas Hospital 9 de Octubre, Valencia
| | - Antonio Montoya-Vieco
- Department of Physical Education and Sports, Universitat de Valencia, Valencia.,Sports Health Unit, Vithas Hospital 9 de Octubre, Valencia
| | - Eladio Collado
- Faculty of Health Sciences, Universitat Jaume I, Castello de la Plana
| | - Bárbara Hernando
- Department of Medicine, Universitat Jaume I, Castello de la Plana
| | - Carlos Hernando
- Sports Service, Universitat Jaume I, Castello de la Plana.,Department of Education and Specific Didactics, Universitat Jaume I, Castello de la Plana
| |
Collapse
|
10
|
Hernando B, Gil-Barrachina M, Tomás-Bort E, Martinez-Navarro I, Collado-Boira E, Hernando C. The effect of long-term ultra-endurance exercise and SOD2 genotype on telomere shortening with age. J Appl Physiol (1985) 2020; 129:873-879. [DOI: 10.1152/japplphysiol.00570.2020] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Habitual ultra-endurance exercise seems to promote telomere length maintenance, especially at older ages. In addition, the beneficial effect of ultra-endurance training on biological aging is higher in ultra-trail runners who have been engaged to ultra-endurance training during many years. Finally, and for the first time, this study shows that the SOD2 rs4880 polymorphism has a significant impact on telomere length, as well as on acute inflammatory response to a 107-km trail race.
Collapse
Affiliation(s)
| | | | | | - Ignacio Martinez-Navarro
- Department of Physical Education and Sport, University of Valencia, Valencia, Spain
- Sports Health Unit, Vithas-Nisa 9 de Octubre Hospital, Valencia, Spain
| | | | - Carlos Hernando
- Sport Service, Jaume I University, Castellon, Spain
- Department of Education and Specific Didactics, Jaume I University, Castellon, Spain
| |
Collapse
|
11
|
Martínez-Navarro I, Sanchez-Gómez JM, Aparicio I, Priego-Quesada JI, Pérez-Soriano P, Collado E, Hernando B, Hernando C. Effect of mountain ultramarathon distance competition on biochemical variables, respiratory and lower-limb fatigue. PLoS One 2020; 15:e0238846. [PMID: 32915883 PMCID: PMC7485829 DOI: 10.1371/journal.pone.0238846] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2020] [Accepted: 08/25/2020] [Indexed: 12/26/2022] Open
Abstract
The study aimed at assessing the acute physiological effects of running a 65-km vs a 107-km mountain ultramarathon. Nineteen athletes (15 males and 4 females) from the shorter race and forty three athletes (26 males and 17 females) from the longer race were enrolled. Body weight, respiratory and lower limb strength were assessed before and after the race. Blood samples were obtained before, after and 24-h post-race. Body weight loss did not differ between races. A decrease in squat jump height (p<0.01; d = 1.4), forced vital capacity (p<0.01; d = 0.5), forced expiratory volume in 1 s (p<0.01; d = 0.6), peak inspiratory flow (p<0.01; d = 0.6) and maximal inspiratory pressure (p<0.01; d = 0.8) was observed after the longer race; while, after the shorter race only maximal inspiratory pressure declined (p<0.01; d = 0.5). Greater post-race concentrations of creatine kinase (p<0.01; d = 0.9) and C-reactive protein (p<0.01; d = 2.3) were observed following the longer race, while high-sensitivity cardiac troponin was higher after the shorter race (p<0.01; d = 0.3). Sodium decreased post-competition only after the shorter race (p = 0.02; d = 0.6), while creatinine increased only following the longer race (p<0.01; d = 1.5). In both groups, glomerular filtration rate declined at post-race (longer race: p<0.01, d = 2.1; shorter race: p = 0.01, d = 1.4) and returned to baseline values at 24 h post-race. In summary, expiratory and lower-limb fatigue, and muscle damage and inflammatory response were greater following the longer race; while a higher release of cardiac troponins was observed after the shorter race. The alteration and restoration of renal function was similar after either race.
Collapse
Affiliation(s)
- Ignacio Martínez-Navarro
- Physical Education and Sports Department, University of Valencia, Valencia, Spain
- Sports Health Unit, Vithas 9 de Octubre Hospital, Valencia, Spain
| | - Juan Miguel Sanchez-Gómez
- Sports Health Unit, Vithas 9 de Octubre Hospital, Valencia, Spain
- University Clinical Hospital of Valencia, Valencia, Spain
| | - Inma Aparicio
- Research Group in Sports Biomechanics (GIBD), Physical Education and Sports Department, University of Valencia, Valencia, Spain
- AITEX (Textil Research Institute), Alcoy, Spain
| | - Jose Ignacio Priego-Quesada
- Research Group in Sports Biomechanics (GIBD), Physical Education and Sports Department, University of Valencia, Valencia, Spain
| | - Pedro Pérez-Soriano
- Research Group in Sports Biomechanics (GIBD), Physical Education and Sports Department, University of Valencia, Valencia, Spain
| | - Eladio Collado
- Faculty of Health Sciences, Jaume I University, Castellon, Spain
| | | | - Carlos Hernando
- Sport Service, Jaume I University, Castellon, Spain
- Department of Education and Specific Didactics, Jaume I University, Castellon, Spain
| |
Collapse
|
12
|
Martínez-Navarro I, Montoya-Vieco A, Collado E, Hernando B, Panizo N, Hernando C. Muscle Cramping in the Marathon: Dehydration and Electrolyte Depletion vs. Muscle Damage. J Strength Cond Res 2020; 36:1629-1635. [PMID: 32796418 DOI: 10.1519/jsc.0000000000003713] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Martínez-Navarro, I, Montoya-Vieco, A, Collado, E, Hernando, B, Panizo, N, and Hernando, C. Muscle Cramping in the marathon: Dehydration and electrolyte depletion vs. muscle damage. J Strength Cond Res XX(X): 000-000, 2020-Our aim was to compare dehydration variables, serum electrolytes, and muscle damage serum markers between runners who suffered exercise-associated muscle cramps (EAMC) and runners who did not suffer EAMC in a road marathon. We were also interested in analyzing race pacing and training background. Nighty-eight marathoners took part in the study. Subjects were subjected to a cardiopulmonary exercise test. Before and after the race, blood and urine samples were collected and body mass (BM) was measured. Immediately after the race EAMC were diagnosed. Eighty-eight runners finished the marathon, and 20 of them developed EAMC (24%) during or immediately after the race. Body mass change, post-race urine specific gravity, and serum sodium and potassium concentrations were not different between crampers and noncrampers. Conversely, runners who suffered EAMC exhibited significantly greater post-race creatine kinase (464.17 ± 220.47 vs. 383.04 ± 253.41 UI/L, p = 0.034) and lactate dehydrogenase (LDH) (362.27 ± 72.10 vs. 307.87 ± 52.42 UI/L, p = 0.002). Twenty-four hours post-race also values of both biomarkers were higher among crampers (CK: 2,438.59 ± 2,625.24 vs. 1,166.66 ± 910.71 UI/L, p = 0.014; LDH: 277.05 ± 89.74 vs. 227.07 ± 37.15 UI/L, p = 0.021). The difference in the percentage of runners who included strength conditioning in their race training approached statistical significance (EAMC: 25%, non-EAMC: 47.6%; p = 0.074). Eventually, relative speed between crampers and noncrampers only differed from the 25th km onward (p < 0.05). Therefore, runners who suffered EAMC did not exhibit a greater degree of dehydration and electrolyte depletion after the marathon but displayed significantly higher concentrations of muscle damage biomarkers.
Collapse
Affiliation(s)
- Ignacio Martínez-Navarro
- Physical Education and Sports Department, University of Valencia, Valencia, Spain.,Sports Health Unit, Vithas Hospital October 9, Valencia, Spain
| | - Antonio Montoya-Vieco
- Physical Education and Sports Department, University of Valencia, Valencia, Spain.,Sports Health Unit, Vithas Hospital October 9, Valencia, Spain
| | - Eladio Collado
- Faculty of Health Sciences, Jaume I University, Castellon, Spain
| | | | - Nayara Panizo
- Department of Medicine, Jaume I University, Castellon, Spain.,Universitary Clinical Hospital of Valencia
| | - Carlos Hernando
- Sport Service, Jaume I University, Castellon, Spain.,Department of Education and Specific Didactics, Jaume I University, Castellon, Spain
| |
Collapse
|
13
|
Martínez-Navarro I, Aparicio I, Priego-Quesada JI, Pérez-Soriano P, Collado E, Hernando B, Hernando C. Effects of wearing a full body compression garment during recovery from an ultra-trail race. Eur J Sport Sci 2020; 21:811-818. [DOI: 10.1080/17461391.2020.1783369] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Affiliation(s)
- Ignacio Martínez-Navarro
- Physical Education and Sports Department, University of Valencia, Valencia, Spain
- Sports Health Unit, Valencia, Spain
| | - Inma Aparicio
- Research Group in Sports Biomechanics (GIBD), Physical Education and Sports Department, University of Valencia, Valencia, Spain
- AITEX (Textil Research Institute), Alcoy, Spain
| | - Jose Ignacio Priego-Quesada
- Research Group in Sports Biomechanics (GIBD), Physical Education and Sports Department, University of Valencia, Valencia, Spain
| | - Pedro Pérez-Soriano
- Research Group in Sports Biomechanics (GIBD), Physical Education and Sports Department, University of Valencia, Valencia, Spain
| | - Eladio Collado
- Faculty of Health Sciences, Jaume I University, Castellon, Spain
| | | | - Carlos Hernando
- Sport Service, Jaume I University, Castellon, Spain
- Department of Education and Specific Didactics, Jaume I University, Castellon, Spain
| |
Collapse
|
14
|
Martínez-Navarro I, Sánchez-Gómez J, Sanmiguel D, Collado E, Hernando B, Panizo N, Hernando C. Immediate and 24-h post-marathon cardiac troponin T is associated with relative exercise intensity. Eur J Appl Physiol 2020; 120:1723-1731. [PMID: 32468283 DOI: 10.1007/s00421-020-04403-8] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2020] [Accepted: 05/19/2020] [Indexed: 10/24/2022]
Abstract
PURPOSE We aimed at exploring whether cardiopulmonary fitness, echocardiographic measures and relative exercise intensity were associated with high-sensitivity cardiac troponin T (hs-TNT) rise and normalization following a marathon. METHODS Nighty-eight participants (83 men, 15 women; 38.72 ± 3.63 years) were subjected to echocardiographic assessment and a cardiopulmonary exercise test (CPET) before the race. hs-TNT was measured before, immediately after and at 24, 48, 96, 144 and 192 h post-race. Speed and mean heart rate (HR) during the race were relativized to CPET values: peak speed (%VVMAX), peak HR (HR%MAX), speed and HR at the second ventilatory threshold (HR%VT2 and %VVT2). RESULTS Hs-TNT increased from pre- to post-race (5.74 ± 5.29 vs. 50.4 ± 57.04 ng/L; p < 0.001), seeing values above the Upper Reference Limit (URL) in 95% of the participants. At 24 h post-race, 39% of the runners still exceeded the URL (High hs-TNT group). hs-TNT rise was correlated with marathon speed %VVT2 (r = 0.22; p = 0.042), mean HR%VT2 (r = 0.30; p = 0.007), and mean HR%MAX (r = 0.32; p = 0.004). Moreover, the High hs-TNT group performed the marathon at a higher Speed %VVT2 (88.21 ± 6.53 vs. 83.49 ± 6.54%; p = 0.002) and Speed %VVMAX (72 ± 4.25 vs. 69.40 ± 5.53%; p = 0.009). hs-TNT showed no significant associations with cardiopulmonary fitness and echocardiographic measures, except for a slight correlation with left ventricular end systolic diameter (r = 0.26; p = 0.018). CONCLUSION Post-race hs-TNT was above the URL in barely all runners. Magnitude of hs-TNT rise was correlated with exercise mean HR; whereas, its normalization kept relationship with marathon relative speed.
Collapse
Affiliation(s)
- Ignacio Martínez-Navarro
- Physical Education and Sports Department, Faculty of Physical Activity and Sport Sciences, University of Valencia, C/Gascó Oliag 3, 46010, Valencia, Spain. .,Sports Health Unit, Vithas 9 de Octubre Hospital, Valencia, Spain.
| | - J Sánchez-Gómez
- Sports Health Unit, Vithas 9 de Octubre Hospital, Valencia, Spain.,Universitary Clinical Hospital of Valencia, Valencia, Spain
| | - D Sanmiguel
- Sports Health Unit, Vithas 9 de Octubre Hospital, Valencia, Spain.,General Hospital of Valencia, Valencia, Spain
| | - E Collado
- Faculty of Health Sciences, Jaume I University, Castellón de la Plana, Castellon, Spain
| | - B Hernando
- Department of Medicine, Jaume I University, Castellón de la Plana, Castellon, Spain
| | - N Panizo
- Faculty of Health Sciences, Jaume I University, Castellón de la Plana, Castellon, Spain.,Universitary Doctor Peset Hospital of Valencia, Valencia, Spain
| | - C Hernando
- Sport Service, Jaume I University, Castellón de la Plana, Castellon, Spain.,Department of Education and Specific Didactics, Jaume I University, Castellón de la Plana, Castellon, Spain
| |
Collapse
|
15
|
Hernando C, Hernando C, Martinez-Navarro I, Collado-Boira E, Panizo N, Hernando B. Estimation of energy consumed by middle-aged recreational marathoners during a marathon using accelerometry-based devices. Sci Rep 2020; 10:1523. [PMID: 32001789 PMCID: PMC6992743 DOI: 10.1038/s41598-020-58492-8] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2019] [Accepted: 01/15/2020] [Indexed: 11/09/2022] Open
Abstract
As long-distance races have substantially increased in popularity over the last few years, the improvement of training programs has become a matter of concern to runners, coaches and health professionals. Triaxial accelerometers have been proposed as a one of the most accurate tools to evaluate physical activity during free-living conditions. In this study, eighty-eight recreational marathon runners, aged 30–45 years, completed a marathon wearing a GENEActiv accelerometer on their non-dominant wrist. Energy consumed by each runner during the marathon was estimated based on both running speed and accelerometer output data, by applying the previously established GENEActiv cut-points for discriminating the six relative-intensity activity levels. Since accelerometry allowed to perform an individualized estimation of energy consumption, higher interpersonal differences in the number of calories consumed by a runner were observed after applying the accelerometry-based approach as compared to the speed-based method. Therefore, pacing analyses should include information of effort intensity distribution in order to adjust race pacing appropriately to achieve the marathon goal time. Several biomechanical and physiological parameters (maximum oxygen uptake, energy cost of running and running economy) were also inferred from accelerometer output data, which is of great value for coaches and doctors.
Collapse
Affiliation(s)
- Carlos Hernando
- Sport Service, Jaume I University, Castellon, Spain. .,Department of Education and Specific Didactics, Jaume I University, Castellon, Spain.
| | - Carla Hernando
- Department of Mathematics, Carlos III University of Madrid, Madrid, Spain
| | - Ignacio Martinez-Navarro
- Department of Physical Education and Sport, University of Valencia, Valencia, Spain.,Sports Health Unit, Vithas-Nisa 9 de Octubre Hospital, Valencia, Spain
| | | | - Nayara Panizo
- Faculty of Health Sciences, Jaume I University, Castellon, Spain
| | | |
Collapse
|
16
|
Martínez-Navarro I, Sánchez-Gómez JM, Collado-Boira EJ, Hernando B, Panizo N, Hernando C. Cardiac Damage Biomarkers and Heart Rate Variability Following a 118-Km Mountain Race: Relationship with Performance and Recovery. J Sports Sci Med 2019; 18:615-622. [PMID: 31827345 PMCID: PMC6873135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2019] [Accepted: 07/22/2019] [Indexed: 06/10/2023]
Abstract
This study aimed to assess the release of cardiac damage biomarkers jointly with cardiac autonomic modulation after a mountain ultramarathon. Such knowledge and the possible relationship of these markers with race time is of primary interest to establish possible recommendations upon athletes' recovery and return to training following these competitions. Forty six athletes enrolled in the Penyagolosa Trails CSP115 race (118 km and a total positive elevation of 5439 m) took part in the study. N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitive cardiac troponin T (hs-TNT) concentrations as well as linear and nonlinear heart rate variability (HRV) were evaluated before and after the race. NT-proBNP and hs-TNT significantly increased post-race; fifty percent of the finishers surpassed the Upper Reference Limit (URL) for hs-TNT while 87% exceeded the URL for NT-proBNP. Overall and vagally-mediated HRV were diminished and cardiac autonomic modulation became less complex and more predictable following the race. More pronounced vagal modulation decreases were associated with higher levels of postexertional NT-proBNP. Moreover, rise in hs-TNT and NT-proBNP was greater among faster runners, while pre-race overall and vagally-mediated HRV were correlated with finishing time. Participation in a 118-km ultratrail induces an acute release of cardiac damage biomarkers and a large alteration of cardiac autonomic modulation. Furthermore, faster runners were those who exhibited a greater rise in those cardiac damage biomarkers. In light of these findings, an appropriate recovery period after ultraendurance races appears prudent and particularly important among better performing athletes. At the same time, HRV analysis is shown as a promising tool to assess athletes' readiness to perform at their maximum level in an ultraendurance race.
Collapse
Affiliation(s)
- Ignacio Martínez-Navarro
- Physical Education and Sports Department, University of Valencia, Valencia, Spain
- Sports Health Unit, Vithas-Nisa 9 de Octubre Hospital, Valencia, Spain
| | - Juan M Sánchez-Gómez
- Sports Health Unit, Vithas-Nisa 9 de Octubre Hospital, Valencia, Spain
- General University Hospital of Castellon, Castellon, Spain
| | | | | | - Nayara Panizo
- Faculty of Health Sciences, Jaume I University, Castellon, Spain
- Universitary Clinical Hospital of Valencia, Castellon, Spain
| | - Carlos Hernando
- Education and Especific Didactics Department, Jaume I University, Castellon, Spain
- Sports Service, Jaume I University, Castellon, Spain
| |
Collapse
|
17
|
Adam-Artigues A, Tormo E, Rojo F, Perez-Fidalgo J, Zazo S, Gonzalez-Alonso P, Hernando C, Martínez M, Gambardella V, Poveda J, Simón S, Moragon S, Alonso E, Albanell J, Burgues O, Bermejo B, Eroles P, Lluch A, Cejalvo J, Rovira A. The role of AXL as mechanism of resistance to trastuzumab and a prognostic factor in breast cancer HER2 positive: A translational approach. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz242.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
18
|
Cejalvo J, Moragon S, Ortega B, Hernando C, Martínez M, Gambardella V, Tarazona Llavero N, Roda D, Burgues O, Alonso E, Simón S, Poveda J, Rentero P, Zuñiga S, Bermejo B, Lluch A, Cervantes A. Clinical application of mutational analysis in breast cancer patients: The relevance of PIK3CA analysis for precision medicine. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz242.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
19
|
Cortes J, Martin M, Pernas S, Gomez Pardo P, Lopez-Tarruella S, Gil-Martin M, Manso L, Ciruelos E, Perez-Fidalgo JA, Hernando C, Ademuyiwa FO, Weilbaecher K, Mayer I, Pluard TJ, Martinez Garcia M, Vahdat L, Wach A, Barker D, Romagnoli B, Kaufman PA. Abstract PD1-02: Withdrawn. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-pd1-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was withdrawn by the authors.
Citation Format: Cortes J, Martin M, Pernas S, Gomez Pardo P, Lopez-Tarruella S, Gil-Martin M, Manso L, Ciruelos E, Perez-Fidalgo JA, Hernando C, Ademuyiwa FO, Weilbaecher K, Mayer I, Pluard TJ, Martinez Garcia M, Vahdat L, Wach A, Barker D, Romagnoli B, Kaufman PA. Withdrawn [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr PD1-02.
Collapse
Affiliation(s)
- J Cortes
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - M Martin
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - S Pernas
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - P Gomez Pardo
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - S Lopez-Tarruella
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - M Gil-Martin
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - L Manso
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - E Ciruelos
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - JA Perez-Fidalgo
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - C Hernando
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - FO Ademuyiwa
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - K Weilbaecher
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - I Mayer
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - TJ Pluard
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - M Martinez Garcia
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - L Vahdat
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - A Wach
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - D Barker
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - B Romagnoli
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| | - PA Kaufman
- Ramon y Cajal University Hospital, Madrid, Spain; Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Institute of Oncology IOB, QuironGroup, Madrid and Barcelona, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC Universidad Complutense, Madrid, Spain; Institut Català d'Oncologia (ICO) L'Hospitalet, Barcelona, Spain; Hospital Universitario 12 de Octubre, Madrid, Spain; Hospital Clínico Universitario de Valencia, INCLIVA, CIBERONC, Valencia, Spain; Washington University, St. Louis, MO; Vanderbilt University School of Medicine, Nashville, TN; St Luke's Cancer Institute, Kansas City, MO; Hospital del Mar, Barcelona, Spain; Weill Cornell Medicine, New York, NY; Polyphor Ltd, Allschwil, Switzerland; Darmouth-Hitchcock Medical Center, Lebanon, NH
| |
Collapse
|
20
|
Cortes Castan J, Martín M, Pernas Simon S, Gomez Pardo P, Lopez-Tarruella S, Gil Martin M, Manso L, Ciruelos E, Perez Fidalgo J, Hernando C, Ademuyiwa F, Weilbaecher K, Mayer I, Pluard T, Martinez Garcia M, Vahdat L, Wach A, Barker D, Romagnoli B, Kaufman P. Balixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy272.277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
21
|
Gonzalez Barrallo I, Perez Fidalgo J, Ramirez J, Burgues O, Sorlí J, Portoles O, Hernando C, Salas D, Lluch A. No effect of length time bias on the genomic risk in ER+ HER2-stage I-IIA breast cancer (BC) patients according to diagnosis in a screening programme: An exploratory analysis. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy297.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
22
|
Hernando C, Hernando C, Collado EJ, Panizo N, Martinez-Navarro I, Hernando B. Establishing cut-points for physical activity classification using triaxial accelerometer in middle-aged recreational marathoners. PLoS One 2018; 13:e0202815. [PMID: 30157271 PMCID: PMC6114871 DOI: 10.1371/journal.pone.0202815] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2017] [Accepted: 08/09/2018] [Indexed: 01/11/2023] Open
Abstract
The purpose of this study was to establish GENEA (Gravity Estimator of Normal Everyday Activity) cut-points for discriminating between six relative-intensity activity levels in middle-aged recreational marathoners. Nighty-eight (83 males and 15 females) recreational marathoners, aged 30–45 years, completed a cardiopulmonary exercise test running on a treadmill while wearing a GENEA accelerometer on their non-dominant wrist. The breath-by-breath V̇O2 data was also collected for criterion measure of physical activity categories (sedentary, light, moderate, vigorous, very vigorous and extremely vigorous). GENEA cut-points for physical activity classification was performed via Receiver Operating Characteristic (ROC) analysis. Spearman’s correlation test was applied to determine the relationship between estimated and measured intensity classifications. Statistical analysis were done for all individuals, and separating samples by sex. The GENEA cut-points established were able to distinguish between all six-relative intensity levels with an excellent classification accuracy (area under the ROC curve (AUC) values between 0.886 and 0.973) for all samples. When samples were separated by sex, AUC values were 0.881–0.973 and 0.924–0.968 for males and females, respectively. The total variance in energy expenditure explained by GENEA accelerometer data was 78.50% for all samples, 78.14% for males, and 83.17% for females. In conclusion, the wrist-worn GENEA accelerometer presents a high capacity of classifying the intensity of physical activity in middle-aged recreational marathoners when examining all samples together, as well as when sample set was separated by sex. This study suggests that the triaxial GENEA accelerometers (worn on the non-dominant wrist) can be used to predict energy expenditure for running activities.
Collapse
Affiliation(s)
- Carlos Hernando
- Sport Service, Jaume I University, Castellon, Spain
- Department of Education, Jaume I University, Castellon, Spain
- * E-mail:
| | - Carla Hernando
- Department of Mathematics, Carlos III University of Madrid, Madrid, Spain
| | | | - Nayara Panizo
- Faculty of Health Sciences, Jaume I University, Castellon, Spain
| | | | | |
Collapse
|
23
|
Espinosa J, Madrigal J, De La Cruz AC, Guijarro M, Jimenez E, Hernando C. Short-term effects of prescribed burning on litterfall biomass in mixed stands of Pinus nigra and Pinus pinaster and pure stands of Pinus nigra in the Cuenca Mountains (Central-Eastern Spain). Sci Total Environ 2018; 618:941-951. [PMID: 29146076 DOI: 10.1016/j.scitotenv.2017.08.291] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2017] [Revised: 08/01/2017] [Accepted: 08/29/2017] [Indexed: 06/07/2023]
Abstract
Fire severity, defined as the magnitude of fire effects in an ecosystem, is a key factor to consider in planning management strategies for protecting forests against fire. Although prescribed burning has been used as a fuel reduction tool in forest ecosystems, it is quite limited in the Mediterranean region. Furthermore, little is known about how tree crowns are affected by prescribed underburning aimed at reducing fire severity in conifer stands. As part of an ongoing study to assess the effects of prescribed burning on the tree canopy, litterfall is currently being monitored in a network of experimental plots located in mixed (Pinus nigra and Pinus pinaster) and pure (P. nigra) conifer stands in the Cuenca Mountains (Castilla La Mancha, Spain). A total of 12 study plots (30m×30m) were established in a completely randomized experimental design to determine the effect of burning, with 2 treatments: no burning (control) and burning (i.e. with three replicate plots for each treatment and site). Burning was conducted in May 2016. In each plot, 8 litterfall collectors were installed at regular intervals, according to international protocols (ICP Forests), and all biomass falling into the collectors is being monitored monthly. The specific objective of this study is to assess how prescribed burning affects the rate of generation of foliar and non-foliar litterfall biomass due to the fire. In addition, the Leaf Area Index was estimated before burning and one year later to verify possible changes in the structure of the stands. This information could be used to help minimize the negative impacts of prescribed underburning on litterfall. To our knowledge, this study represents the first attempt to evaluate the effect of prescribed burning on litterfall biomass in Europe.
Collapse
Affiliation(s)
- J Espinosa
- INIA, Forest Research Centre, Department of Silviculture and Forest Management, Forest Fire Laboratory, Ctra. Coruña Km 7.5, 28040 Madrid, Spain.
| | - J Madrigal
- INIA, Forest Research Centre, Department of Silviculture and Forest Management, Forest Fire Laboratory, Ctra. Coruña Km 7.5, 28040 Madrid, Spain; iuFOR, University Institute for Sustainable Forest Management, uVA-INIA, Spain
| | - A C De La Cruz
- INIA, Forest Research Centre, Department of Silviculture and Forest Management, Forest Fire Laboratory, Ctra. Coruña Km 7.5, 28040 Madrid, Spain
| | - M Guijarro
- INIA, Forest Research Centre, Department of Silviculture and Forest Management, Forest Fire Laboratory, Ctra. Coruña Km 7.5, 28040 Madrid, Spain; iuFOR, University Institute for Sustainable Forest Management, uVA-INIA, Spain
| | - E Jimenez
- Forest Research Center of Lourizán. Xunta de Galicia, 36080 Pontevedra, Spain
| | - C Hernando
- INIA, Forest Research Centre, Department of Silviculture and Forest Management, Forest Fire Laboratory, Ctra. Coruña Km 7.5, 28040 Madrid, Spain; iuFOR, University Institute for Sustainable Forest Management, uVA-INIA, Spain
| |
Collapse
|
24
|
Martínez-Navarro I, Chiva-Bartoll O, Hernando B, Collado E, Porcar V, Hernando C. Hydration Status, Executive Function, and Response to Orthostatism After a 118-km Mountain Race: Are They Interrelated? J Strength Cond Res 2018; 32:441-449. [DOI: 10.1519/jsc.0000000000001614] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
25
|
Ferrer L, Gaillardin F, Cayuela A, Felt E, Hernando C, Collazos F, Ronda E, Casabona J. Children health determinants in a multi-site cohort of immigrant families in Spain (PELFI Study). Eur J Public Health 2016. [DOI: 10.1093/eurpub/ckw175.114] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
26
|
Fidalgo JP, Caballero A, Cejalvo J, Burgues O, Hernando C, Tolosa P, Iranzo A, Bermejo B, Sabio JR, Magro A, Lluch-Hernandez A. Long lasting survival (LLS) after removal of primary tumor (PT) in metastatic breast cancer (MBC). Impact of age on outcome. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw365.31] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
27
|
Della Rocca G, Hernando C, Madrigal J, Danti R, Moya J, Guijarro M, Pecchioli A, Moya B. Possible land management uses of common cypress to reduce wildfire initiation risk: a laboratory study. J Environ Manage 2015; 159:68-77. [PMID: 26046989 DOI: 10.1016/j.jenvman.2015.05.020] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/21/2014] [Revised: 03/20/2015] [Accepted: 05/16/2015] [Indexed: 05/23/2023]
Abstract
Accurate determination of flammability is required in order to improve knowledge about vegetation fire risk. Study of the flammability of different plant species is essential for the Mediterranean area, where most ecosystems are adapted to natural fire but vulnerable to recurrent human-induced fires, which are the main cause of forest degradation. However, the methods used to evaluate vegetation flammability have not yet been standardized. Cupressus sempervirens is a native or naturalized forest tree species in the Mediterranean area that is able to tolerate prolonged drought and high temperatures. The aim of this study was to characterize the flammability of C. sempervirens var. horizontalis at particle level by using different bench-scale calorimetry techniques (mass loss calorimeter, epiradiator and oxygen bomb) to determine the main flammability descriptors (ignitability, sustainability, combustibility and consumability) in live crown and litter samples. Our findings indicate that this variety of cypress is relatively resistant to ignition because of the high ash content, the high critical heat flux, the high time to ignition displayed by both crown and litter samples and the ability of the leaves to maintain a high water content during the summer. We also discuss the possibility of exploiting some morphological, functional and ecological traits of the species to construct a barrier system (with selected varieties of cypress) as a promising complementary land management tool to reduce the fire spread and intensity in a Mediterranean context.
Collapse
Affiliation(s)
- G Della Rocca
- Institute for Sustainable Plant Protection, IPSP-CNR, Via Madonna del Piano 10, I-50019, Sesto Fiorentino, FI, Italy.
| | - C Hernando
- INIA - CIFOR, Department of Silviculture and Forest Management, Crta. A Coruña Km 7.5, 28040, Madrid, Spain; Sustainable Forest Management Institute, UVa-INIA, Spain.
| | - J Madrigal
- INIA - CIFOR, Department of Silviculture and Forest Management, Crta. A Coruña Km 7.5, 28040, Madrid, Spain; Sustainable Forest Management Institute, UVa-INIA, Spain.
| | - R Danti
- Institute for Sustainable Plant Protection, IPSP-CNR, Via Madonna del Piano 10, I-50019, Sesto Fiorentino, FI, Italy.
| | - J Moya
- Monumental Trees Department, Imelsa - Valencia Provincial Council, C/ Conde Trenor 9, 46003, Valencia, Spain.
| | - M Guijarro
- INIA - CIFOR, Department of Silviculture and Forest Management, Crta. A Coruña Km 7.5, 28040, Madrid, Spain; Sustainable Forest Management Institute, UVa-INIA, Spain.
| | - A Pecchioli
- Institute for Sustainable Plant Protection, IPSP-CNR, Via Madonna del Piano 10, I-50019, Sesto Fiorentino, FI, Italy.
| | - B Moya
- Monumental Trees Department, Imelsa - Valencia Provincial Council, C/ Conde Trenor 9, 46003, Valencia, Spain
| |
Collapse
|
28
|
Gallach S, Calabuig-Fariñas S, Jantus-Lewintre E, Montaner D, Escorihuela E, Castellano J, Figueroa S, Blasco A, Hernando C, Guijarro R, Camps C. 545 MiRNAs related to KRAS mutational status in resectable non-small cell lung cancer. Eur J Cancer 2014. [DOI: 10.1016/s0959-8049(14)70671-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
29
|
Hernando C. 1.245 HEMICHOREA-HEMIBALLISM: NON KETOTIC HYPERGLYCEMIA SYMPTOM. Parkinsonism Relat Disord 2012. [DOI: 10.1016/s1353-8020(11)70303-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
30
|
Sanmartin E, Gallach S, Sirera R, Hernando C, Honguero A, Guijarro R, Martorell M, Camps C, Jantus-Lewintre E. Prognostic implications of lymphangiogenic markers in early-stage NSCLC. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e21108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
31
|
Vilaró J, Gimeno E, Sánchez Férez N, Hernando C, Díaz I, Ferrerc M, Roca J, Alonso J. Actividades de la vida diaria en pacientes con enfermedad pulmonar obstructiva crónica: validación de la traducción española y análisis comparativo de 2 cuestionarios. Med Clin (Barc) 2007; 129:326-32. [PMID: 17910846 DOI: 10.1157/13109543] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
BACKGROUND AND OBJECTIVE Exercise limitation is a common finding in chronic obstructive pulmonary disease (COPD) patients and has an important role in disease prognosis and the use of health care services. There are no questionnaires in Spanish language that evaluate the impact of the disease in the activities of daily living in these patients. Our objective was to adapt and validate the Spanish versions of 2 standard questionnaires for assessment of physical activity: the London Chest Activity of Daily Living scale (LCADL) and the Modified Baecke Physical Activity Questionnaire (modified Baecke). PATIENTS AND METHOD After carrying out the translation and back-translation, the 2 questionnaires were administered to 55 patients with COPD (mean age [standard deviation]: 66 [8] years; forced expiratory volume in 1 s: 1.2 [0.5] l, 38 [15]%) in 2 occasions and a conventional exercise test was performed. RESULTS Cronbach's alpha coefficient was very high (0.98 and 0.97 for LCADL and modified Baecke, respectively; p < 0.0001 each). Intraclass correlation coefficients of the test re-test reliability was also very high (0.97 and 0.96, respectively). Mean values of the questionnaires in the 2 administrations were 20 (11) vs 19 (11) for LCADL (p = 0.26), and 15 (9) vs 14 (9) for modified Baecke (p = 0.51). The 2 questionnaires showed a significant correlation with quality of life (St. George's Respiratory Questionnaire), dyspnea score (Medical Research Council scale) and 6 min walk test. CONCLUSIONS The Spanish versions of these 2 questionnaires to assess physical activity are relibale and they display the expected association with health related quality of life, dyspnea score, and the 6 min walk test, confirming their validity. Therefore, we propose its use to complement the assessment of physical activity in those patients with COPD in whom direct measurements of this variable are not available.
Collapse
Affiliation(s)
- Jordi Vilaró
- EUIFN Blanquerna, Universitat Ramon Llull, Barcelona, España.
| | | | | | | | | | | | | | | |
Collapse
|
32
|
Madrigal J, Hernando C, Guijarro M, Díez C, Jiménez E. Biomass accumulation and carbon sequestration after heavy mechanical thinning on post-fire Pinus pinaster seedlings (Monte ‘Fraguas’, Guadalajara, Central Spain). ACTA ACUST UNITED AC 2006. [DOI: 10.5424/srf/2006152-00967] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
33
|
de Górgolas M, Erice A, Gil A, Gutiérrez J, Rivas P, Hernando C, Rodríguez MCG. Cryptococcal meningitis in a patient with X-linked hyper-IgM1 syndrome. ACTA ACUST UNITED AC 2005; 37:526-8. [PMID: 16012021 DOI: 10.1080/00365540510036570] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
A case is reported of cryptococcal meningitis in a 27-y-old male suffering from X-linked hyper-IgM1 syndrome. This congenital disorder is characterized by multiple infections of the respiratory and gastrointestinal tracts, but also opportunistic infections commonly seen in patients with cell-mediated immunity. His clinical recovery was good but the need for life-long secondary chemoprophylaxis to prevent relapses is unknown.
Collapse
Affiliation(s)
- Miguel de Górgolas
- División de Enfermedades Infecciosas, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain.
| | | | | | | | | | | | | |
Collapse
|
34
|
Madrigal J, Hernando C, Martinez E, Guijarro M, Diez C. Post-fire regeneration of P. pinaster Ait. in Sierra de Guadarrama (Central Spain): modelling of initial density and survival. ACTA ACUST UNITED AC 2005. [DOI: 10.5424/srf/2005141-00872] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
35
|
Hernando C, Carrera M, Ribas I, Parear N, Baraibar R, Egocue J, Fuster C. Prenatal and postnatal characterization of Y chromosome structural anomalies by molecular cytogenetic analysis. Prenat Diagn 2002; 22:802-5. [PMID: 12224075 DOI: 10.1002/pd.415] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
We describe three cases in which we used fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR) and comparative genomic hybridization (CGH) to characterize Y chromosome structural anomalies, unidentifiable by conventional G-banding. Case 1 was a 46,X,+mar karyotype; FISH analysis revealed an entire marker chromosome highlighted after hybridization with the Y chromosome painting probe. The PCR study showed the presence of Y chromosome markers AMG and SY620 and the absence of SY143, SY254 and SY147. CGH results confirmed the loss of Yq11.2-qter. These results indicated the presence of a deletion: del(Y)(q11.2). Case 2 was a 45,X [14]/46,XY[86] karyotype with a very small Y chromosome. The PCR study showed the presence of Y chromosome markers SY620 and AMG, and the absence of SY143, SY254 and SY147. CGH results showed gain of Yq11.2-pter and loss of Yq11.2-q12. These results show the presence of a Yp isodicentric: idic(Y)(q11.2). Case 3 was a 45,X,inv(9)(p11q12)[30]/46,X,idic(Y)(p11.3?),inv(9)(p11q12)[70] karyotype. The FISH signal covered all the abnormal Y chromosome using a Y chromosome paint. The PCR study showed the presence of Y chromosome markers AMG, SY620, SY143, SY254 and SY147. CGH only showed gain of Yq11.2-qter. These results support the presence of an unbalanced (Y;Y) translocation. Our results show that the combined use of molecular and classical cytogenetic methods in clinical diagnosis may allow a better delineation of the chromosome regions implicated in specific clinical disorders.
Collapse
Affiliation(s)
- C Hernando
- Unitat de Biologia, Facultat de Medicina, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Barcelona, Spain
| | | | | | | | | | | | | |
Collapse
|
36
|
Hernando C, Plaja A, Rigola MA, Pérez MM, Vendrell T, Egocue J, Fuster C. Comparative genomic hybridisation shows a partial de novo deletion 16p11.2 in a neonate with multiple congenital malformations. J Med Genet 2002; 39:E24. [PMID: 12011165 PMCID: PMC1735111 DOI: 10.1136/jmg.39.5.e24] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
37
|
Cubells JM, de Blas A, Hernando C, Rodríguez del Barrio E. [Bovine cerebral cortex gangliosides in the treatment of radicular lesions (author's transl)]. Med Clin (Barc) 1980; 75:156-60. [PMID: 7412438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Bovine cerebral cortex gangliosides were given to 71 patients following surgical intervention for radicular compression of different etiologies. The extract was given for 20-25 days at daily doses of 20 mg for the first 15 days and 10 mg thereafter until completion of treatment. H reflexology was shown to be a good method for evaluating the response to therapy. Most information was gained by the use of the following parameters: AM/AH, AH/IE, and AH/number of stimulation pulses. The results have been compared with those obtained prior to surgical therapy, those collected in a series of 68 normal individuals and, finally, with those found in another series of 71 patients that were treated postoperatively with conventional measures (B vitamins, analgesics, antiinflammatory drugs, corticoids, etc.). The statistical analysis of the final data shows that the reflexologic parameters tested revert to normal quicker in the patients treated with gangliosides than in those not receiving such therapy. The authors consider the use of gangliosides of great interest in the postoperative period after surgical relief of radicular compression.
Collapse
|
38
|
Hernando C, De Blas A, Cubells JM. [Cytidine diphosphate cholinne -- a new drug in the treatment of spasticity]. Rev Clin Esp 1978; 151:313-7. [PMID: 741011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
39
|
Villarejo FJ, Hernando C, Roda E. [Aneurysms of distal anterior cerebral artery (author's transl)]. Rev Esp Otoneurooftalmol Neurocir 1975; 33:229-36. [PMID: 1230931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
40
|
|
41
|
Odoriz B, Hernando C, Dierssen G. [Various observations on cerebral atrophy due to small subcortical injuries]. Rev Clin Esp 1969; 112:261-74. [PMID: 5345179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
42
|
Dierssen G, Hernando C, Odoriz B. [Effects of stimulation of the posterior cingular region in man]. Rev Clin Esp 1969; 112:15-26. [PMID: 5766955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
43
|
Dierssen G, Hernando C, Odoriz B. [Influence of subcortical stimulation on the tremor and rigidity of Parkinson's disease]. Rev Clin Esp 1968; 111:513-8. [PMID: 4894970] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
44
|
Dierssen G, Hernando C, Odoriz B. [Observations on the influence of the pyramidal lesion in Parkinson's homolateral tumor]. Rev Clin Esp 1968; 111:63-6. [PMID: 5742417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
45
|
Sánchez Moreno G, Dierssen G, Hernando C. [Study of sensorial representations of the median supracallous cortex in the cat using evoked potentials. 2. Tongue. Hypoglossal nerve and the lingual propioceptive sensitivity]. Rev Clin Esp 1966; 102:270-4. [PMID: 5993266] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|